The TLX1/HOX11 homeobox gene was originally identified at the recurrent t(10;14)(q24;q11) translocation breakpoint, a chromosomal abnormality observed in 5-7% of T-cell acute lymphoblastic leukemias (T-ALLs). Proviral insertional mutagenesis studies performed on transgenic mice ectopically expressing TLX1/HOX11 in B lymphocytes Tg mice) revealed the Ubr1 gene locus as a frequent site of proviral insertion, concomitant with accelerated development of diffuse large B-cell lymphoma. Insertion into this genomic region was confirmed by Southern blotting and by the ability to generate a polymerase chain reaction (PCR) amplicon across the viral-genome junction. Western immunoblot and semiquantitative reverse transcriptase-PCR analysis revealed downregulated expression of the Ubr1 gene product subsequent to viral integration. Loss or reduced levels of Ubr1 expression was associated with 5/14 spontaneous B-cell lymphomas in IgHl-HOX11 Tg mice and one of nine primary human T-ALLs. To gain mechanistic insight into the cooperativity between TLX1/HOX11 and Ubr1, IgHl-HOX11 Tg /Ubr1 À/À mice were generated. IgHl-HOX11 Tg /Ubr1 À/À mice exhibited a modest but statistically significant acceleration of disease onset relative to IgHl-HOX11 Tg 
/Ubr1
þ /À mice. Moreover, micronucleus assays to detect for chromosome missegregation were conducted and revealed increased presence of micronuclei in IgHl-HOX11 Tg 
À/À primary B lymphocyte cultures, and in both TLX1/ HOX11-overexpressing T cell lines and fibroblast cultures following transfection with short interfering RNAs (siRNAs) targeting Ubr1. Karyotyping of primary B lymphocyte cultures revealed increased incidences of hypodiploid karyotypes. Finally, mitotic figures analysed from Ubr1 siRNA-transfected fibroblast cultures revealed no defects in chromosome congression to the metaphase plate, but increased incidences of atypical anaphase figures, including the development of anaphase bridges and lagging chromosomes. Based on these findings, we identify a synergistic role between TLX1/HOX11 overexpression and Ubr1 inactivation in promoting chromosome missegregation, permitting the accrual of additional chromosome losses and cytogenic abnormalities en route to malignancy.
Introduction
The homeobox gene, TLX1/HOX11 (here after referred to as HOX11), was originally identified at the recurrent t(10;14)(q24;q11) translocation breakpoint, a chromosomal abnormality observed in 5-7% of pediatric T-cell acute lymphoblastic leukemias (T-ALLs) (Dube´et al., 1986 (Dube´et al., , 1991 Hatano et al., 1991; Kennedy et al., 1991) . The translocation results in the aberrant fusion of the T-cell receptor a/d regulatory elements on chromosome 14 with the HOX11 coding region on chromosome 10, resulting in inappropriate and deregulated expression of HOX11 in thymocytes and peripheral T lymphocytes. Ordinarily not expressed in T cells, the abnormal presence of HOX11 subsequent to the t(10;14) rearrangement event was believed to be an early genetic hit en route to T lymphocyte immortalization. Overexpression of HOX11 by retroviral transduction was able to immortalize murine hematopoietic and embryonic precursors and transform bone marrow cells (Hawley et al., 1994 (Hawley et al., , 1997 Keller et al., 1998) . Moreover, transgenic mouse lines that ectopically expresses HOX11 in B cells Tg mice) develop a mature IgM þ IgD þ B-cell lymphoma within 2 years, further validating the oncogenic role of HOX11 in vivo (Hough et al., 1998) . In these mice, a pre-malignant phase characterized by lymphoid hyperplasia was detected in the spleens of mice as young as 6 weeks of age, followed by the onset of a mature marginal zone B-cell lymphoma in the second year of life. Although the spleen was typically the primary site of lymphomagenesis, there was frequent dissemination to distant sites, including the thymus, lymph nodes, lungs and kidneys. The extended latency before the development of lymphoma in the IgHm-HOX11 Tg mice, however, suggested that additional genetic lesions, in combination with ectopic expression of HOX11, were necessary to convert splenic hyperplasia to malignant lymphoma. IgHm-HOX11 Tg mice, therefore, represent a unique model for studying and identifying genetic pathways underlying the pathogenesis of HOX11-mediated lymphomagenesis.
In an effort to identify genes that synergized with HOX11 in B-cell lymphomagenesis, we performed a proviral insertional mutagenesis screen in IgHm-HOX11 Tg mice. The 17 putative HOX11 collaborators in lymphomagenesis were identified. Surprisingly, a significant number of the identified targets (7/17) were revealed to participate in the regulation of chromosome segregation during mitosis (Chen et al., 2006) . Among them, the Ubr1 gene locus on mouse chromosome 2 was identified as a recurrent integration site.
The Ubr1 gene encodes a member of the E3 ubiquitin ligase family of proteins, responsible for facilitating the direct ubiquitination of substrate proteins as a mechanism for designating proteins destined for proteosomal degradation (Varshavsky, 1996) . UBR1 belongs to a larger family of E3 ubiquitin ligases characterized by a B70 amino-acid zinc-finger-like domain called the UBR box, of which seven members are currently known (Tasaki et al., 2005) . Functionally, the UBR1 protein recognizes and targets protein substrates possessing a destabilizing N-terminal residue degradation signal, in a process designated the N-end rule. The N-end rule pathway has been detected in all eukaryotes examined thus far, and has been shown to function in the regulation of apoptosis (Ditzel et al., 2003) , meiosis in yeasts and metazoans (Kwon et al., 2003) , leaf senescence in plants (Yoshida et al., 2002) , cardiovascular development in mammals (Kwon et al., 2002) and fidelity of chromosome segregation (Rao et al., 2001) . Other targets of the N-end rule pathway include RNA polymerases of alphaviruses (de Groot et al., 1991) , the integrase of the human immunodeficiency virus type 1 (Mulder and Muesing, 2000) , the 3C protease of encephalomyocarditis virus (Lawson et al., 1999) and mammalian G proteins (Hamilton et al., 2003) . However, the functions of the N-end rule pathway in animal physiology remain unclear. Ubr1 À/À mice are viable and display only subtle defects in muscle protein degradation and fat metabolism (Kwon et al., 2001) . Moreover, there was no predisposition to the development of malignancies in these animals.
In this report, we characterize the identification of the Ubr1 gene locus as a frequently disrupted site in murine AIDS (mAIDS)-accelerated B-cell lymphomagenesis in IgHm-HOX11 Tg mice, and report the spontaneous loss of Ubr1 as a rare genetic event in HOX11-positive lymphomas. We generated a IgHm-HOX11 Tg /Ubr1 À/À mouse line which exhibited a modest but statistically significant acceleration in onset of a mature, germinal center-derived diffuse large B-cell lymphoma (DLBCL).
Primary B lymphocyte cultures derived from the IgHm-HOX11
Tg /Ubr1 À/À mice exhibited increased susceptibility to chromosome missegregation and the development of hypoploid karyotypes, a possible precursor to cancer evolution in these animals.
Results
Frequent proviral insertions in the murine Ubr1 gene of IgHm-HOX11 Tg mice The Ubr1 gene locus was previously identified as an integration site in an insertional mutagenesis screen of IgHm-HOX11 Tg mice using the Du5H mAIDS virus (Chen et al., 2006) . Nine of 10 animals infected with the mAIDS virus exhibited accelerated development of a mature B-cell lymphoma manifested by the appearance of thymic tumors comprised of mature B lymphocytes. In contrast, all 10 infected control littermates remained asymptomatic up to one year post-inoculation, and only two control animals (WT186 and WT175) exhibited the presence of small thymic masses. A polymerase chain reaction (PCR)-based screen to identify mAIDS integration sites in the nine thymic tumors derived from the affected IgHm-HOX11 Tg mice revealed the Ubr1 gene as a frequent site of proviral integration, with three animals (TG177, TG179, TG188) bearing insertions of the mAIDS virus into exon 10 of the mouse Ubr1 gene (Figure 1a and b). TG177 and TG179 harbored a common insertion at nucleotide 1295 of the Ubr1 coding region, whereas TG188 exhibited an insertion 44 nucleotides upstream at nucleotide 1251. In contrast, similar analysis on thymus samples from four age-matched, wild-type (WT) animals (WT175, WT178, WT185, WT186) did not amplify PCR products. Although this does not eliminate the possibility of proviral integration within the Ubr1 gene in the control animals, it indicates that subsequent clonal expansion of B lymphocytes bearing insertions in the Ubr1 gene was restricted to IgHm-HOX11 Tg mice. Proviral insertion into exon 10 was confirmed by PCR amplification across the virus-genome border (Figure 1c) . Similar viralgenome junction fragments were not amplifiable in WT controls or in a fourth IgHm-HOX11
Tg animal (TG180) in which the Ubr1 alleles had not been altered by proviral integration. Moreover, Southern blot analysis of thymic tumor DNA confirmed rearrangement of the Ubr1 allele in TG177, TG179 and TG188 (Figure 1c) .
To determine whether integration of proviral sequences into Ubr1 affected gene expression, semiquantitative reverse transcriptase-PCR (RT-PCR) to assess levels of Ubr1 mRNA was performed on thymic tumor samples. We observed diminution of Ubr1 mRNA levels in TG177, TG179 and TG188 relative to the four age-matched, WT controls (Figure 2a ), suggesting that Ubr1 mRNA abundance was significantly reduced in thymic tumors comprised of B lymphocytes harboring an integration within the Ubr1 gene. In conjunction with reduced Ubr1 mRNA abundance, Ubr1-mAIDS chimeric mRNA transcripts were also detected at low levels in TG177, TG179 and TG188.
Western immunoblot analysis of crude tumor lysates revealed downregulation of the 220 kDa UBR1 protein species in the thymic tumors of the three animals harboring a proviral integration within Ubr1 relative to WT controls and transgenic mice which did not exhibit disruption of the Ubr1 gene (Figure 2b) . Levels of the UBR1-binding partner, UBC2 (Kwon et al., 2001) , the homeodomain-containing HOX11-binding partner, PBX1 and b-actin were unaltered, suggesting that this decrease was not a global event. Despite the presence of the chimeric Ubr1-mAIDS transcripts, no corresponding truncated UBR1 peptides (predicted to migrate between 38 and 41 kDa, including seven amino acids contributed by the mAIDS transcript before the introduction of a TAG stop codon) were detectable. As the levels of the chimeric transcripts were very low, the inability to detect the truncated peptides may be due to an insufficient sensitivity during the immunoblotting procedure or may reflect a short halflife of the truncated peptide within the cell. Analysis of the truncated peptide using the ProSITE software did not reveal potential functional domains that may allow the truncated peptide to act as a dominantnegative inhibitor. Additionally, the truncated UBR1 peptide lacked the RING domain necessary for conjugation with target proteins before ubiquitination and targeting to the proteosome. Although we cannot definitively rule out the possibility of a dominantnegative effect, the lack of the RING domain in conjunction with deletion of in excess of 80% of the coding region of the normal UBR1 protein suggests that the truncated UBR1 peptide is unlikely to be biologically active and the insertion within the Ubr1 gene likely represents a null mutation.
Despite the downregulation of UBR1 subsequent to proviral disruption, residual mRNA and protein remained detectable by semiquantitative RT-PCR and immunoblotting, respectively, indicating that the inactivation of UBR1 was incomplete. We surmised that this residual expression could be derived from three sources: (1) non-B cells resident within the tumor, including myeloid, stromal or T cells; (2) a distinct pool of transformed and clonogenically expanded B lymphocytes not harboring a Ubr1 integration but rather an alternate oncogenic event or (3) gene expression derived from the second, non-disrupted Ubr1 allele of those B lymphocytes harboring a Ubr1 integration. To address these possibilities, B220
þ sorted B cells were isolated from the thymic tumors of WT186 and TG188 and assessed for UBR1 protein levels. These analyses revealed a more pronounced diminution of UBR1 protein levels in the B220 þ B-cell population of TG188 relative to the unsorted tumor lysate and to the B220 À non-B-cell population ( Figure 2c ). UBR1 expression was unaltered in the B220 þ fractions from the WT186 control thymic tumor, indicating the decrease was not a B-cell-specific phenomenon. Collectively, this indicates that a significant proportion of the residual UBR1 protein detected in the total tumor lysates from TG188 (and presumably TG177 and TG179) could be accounted for by the UBR1 expression in the non-B cells within the tumor. To further clarify whether the haploinsufficiency resulting from a single copy loss of Ubr1 or whether loss of both Ubr1 alleles was sufficient for cellular transformation, single-cell RT-PCR was performed on individual, fluorescence-activated cell sorting (FACS)-sorted B220 However, these studies do not establish whether there was a loss of heterozygosity at a second Ubr1 locus or whether there was a simultaneous tandem hit of both Ubr1 alleles en route to malignancy.
Ubr1 is spontaneously lost in a subset of lymphoid malignancies To assess the relevance of loss of Ubr1 expression in B-cell lymphomagenesis, levels of Ubr1 protein were assessed on a panel of 14 spontaneously arising splenic B-cell malignancies derived from IgHm-HOX11 Tg mice in order to determine the frequency of spontaneous loss of Ubr1 in the natural progression of HOX11-mediated lymphomas. Western immunoblot revealed three tumors devoid of UBR1 expression, whereas two additional tumors exhibited reduced levels of UBR1 expression relative to levels in purified B cells isolated from pre-malignant IgHm-HOX11
Tg animals ( Figure 3a) .
To determine whether Ubr1 loss was a clinically relevant genetic event in human lymphomas, Ubr1 mRNA levels were assessed in three T-ALL cell lines (Jurkat, K3P, SIL) and nine primary T-ALLs by both semiquantitative RT-PCR ( Figure 3b , top panel) and by real-time quantititative RT-PCR (qPCR) (Figure 3b , bottom panel). Of the cell lines, Jurkat cells do not express HOX11, whereas the K3P and SIL cell lines were derived from T-ALL patients harboring a t(10;14) translocation and express high levels of the HOX11 protein. Of the primary T-ALLs, one sample (#9) was verified to be HOX11 positive. Ubr1 expression was unaltered among the three cell lines examined. However, both semiquantitative and qPCR experiments revealed a significant decline in Ubr1 mRNA expression in one patient (#7). Although more samples will be required to better validate the role of Ubr1 loss in lymphomagensis, this preliminary screen suggests that Ubr1 loss may contribute to the progression of T-ALLs (albeit, infrequently) in humans. Of 96 single-cell samples processed, 32 and 24 single cells from WT186 and TG188, respectively, exhibited successful amplification of the B220 gene product. Of the 32 from WT186, 24 were examined and all were revealed to exhibit Ubr1 expression. Of the 24 from TG188, 16 exhibited Ubr1 expression whereas eight exhibited no Ubr1 expression. The positive control ( þ ) was a single-cell preparation of splenocytes derived from Ubr1 þ /À mice to ensure sufficient assay sensitivity to amplify products derived from one allele. The negative control (À) was a single-cell preparation of splenocytes derived from Ubr1 À/À mice. Quantitative real-time RT-PCR (qPCR) of Ubr1 mRNA expression of the same samples (bottom). Ubr1 mRNA levels were standardized to an internal B220 control and expressed relative to the Jurkat T-ALL sample, which was arbitrarily designated as 1.00. All samples were performed in triplicate. (Figure 4a) . Moreover, IgHm-HOX11 Tg /Ubr1 À/À mice exhibited a statistically significant increase in spleen mass, concomitant with increased total spleen cellularity and absolute B-cell numbers, indicative of a B-cell hyperproliferative disorder (Figure 4a ). Histopathological analyses of spleen sections revealed a loss of splenic follicular structure in seven of nine mice exhibiting accelerated disease, with diffuse infiltration of the splenic red pulp with a large pleomorphic centroblast population containing prominent nucleoli and open chromatin reminiscent of mature B lymphocytes originating in the germinal center (compare Figure 4c and d to normal spleen section in Figure 4b ). These characteristics are consistent with a diagnosis of a germinal center-derived DLBCL, based on the Bethesda proposal for classification of lymphoid neoplasms in mice (Morse et al., 2002) . Dissemination of lymphomatous tissue to the lung was seen in one animal (Figure 4e ). The remaining two animals developed CD45-negative, B220-negative, non-B-cell malignancies, with histological characteristics of an endotheloid hemangioma (Table 1) .
B-cell lymphomagenesis in transgenic mice
The Ubr1 gene encodes an E3 ubiquitin ligase of the N-end rule pathway of the ubiquitin-dependent proteolytic degradation processes (Kwon et al., 2001) . Substrates of the N-end rule pathway include proteins with destabilizing N-terminal residues. Although the mammalian proteins whose in vivo degradation depends on the E3 activity of UBR1 remain unknown, it has been reported that in Saccharomyces cerevisiae, a subunit of the cohesin complex, SCC1, is cleaved by the ESP1 separase at the metaphase-anaphase transition, yielding a C-terminal Arg-SCC1 fragment that is degraded by yeast UBR1 (Rao et al., 2001) . S. cerevisiae mutant cells lacking UBR1 possess long-lived SCC1 protein and consequently exhibit loss of fidelity of chromosome maintenance with increased incidences of chromosome loss. Therefore, we speculated that loss of Ubr1 in HOX11 cells might contribute to lymphomagenesis by facilitating chromosome missegregation. To address this possibility, we assayed the extent of accumulation of micronuclei formation, representative of improper chromosome segregation during anaphase and subsequent chromosome loss. Primary B lymphocyte cultures were established from WT, IgHm-HOX11 
À/À spleens exhibiting lymphocytic infiltration of red pulp (c and d) and lung (e).
B-cell lymphomagenesis in transgenic mice E Chen et al
lymphomagenesis by the accumulation of chromosome losses and aneuploidy.
HOX11 overexpression and Ubr1 loss leads to aneuploidy in K3P and SIL T-ALL cell lines Given that HOX11 was originally identified as a T-cellspecific oncogene, we further assessed collaboration of HOX11 and UBR1 in the HOX11-positive T-ALL cells lines, K3P and SIL, transiently transfected with short interfering RNA (siRNA) targeting Ubr1. Western immunoblot analyses revealed a dramatic downregulation of UBR1 protein levels following transfection of both K3P and SIL cultures with Ubr1 siRNA, which was not seen in cultures transfected with a control, scrambled RNA oligonucleotide (Figure 6a ). HOX11 levels were unaffected by the fluctuating UBR1 levels. Similar to the primary B lymphocyte cultures, Ubr1 siRNA-transfected cultures and control-transfected cultures did not exhibit significant differences in growth kinetics or differential responses to apoptosis. However, Ubr1 siRNA-transfected K3P and SIL cultures did exhibit elevated micronucleus positive events (for K3P, 4.8%, s.d. ¼ 1.3%, P ¼ 0.008 relative to control transfected; for SIL, 3.8%, s.d. ¼ 1.9%, P ¼ 0.03 relative to control transfected) following 3 days of culture (Figure 6b ), suggesting that the lowered levels of Ubr1 in the presence of ectopically expressed HOX11 in a T-cell context also led to an increased propensity for accumulation of defects in chromosome segregation.
HOX11 overexpression and Ubr1 loss leads to aneuploidy in NIH 3T3 fibroblasts concomitant with abnormal anaphase Further corroborative studies were performed using NIH 3T3 fibroblast cell lines stably expressing the HOX11 oncoprotein (HOX11-3T3) transiently transfected with the Ubr1-specific siRNA ( Figure 6c ). As with the B-and T-cell systems, we observed statistically significant increases in micronucleus-positive events following Ubr1 knockdown (21.4%, s.d. ¼ 4.9%, P ¼ 0.022 relative to mock HOX11-3T3 cultures) relative to the control-transfected HOX11-3T3 cultures (3.6%, s.d. ¼ 1.8%, P ¼ 0.52) (Figure 6d ). The increased robustness of micronucleus induction in the 3T3 system may be due to the increased doubling rate of these cells relative to the primary B-cell cultures and the T cell lines. Alternatively, it may reflect a more compromised checkpoint in the 3T3 fibroblast cell lines relative to the other lymphoid cells. The increased robustness of the chromosome missegregation phenotype in the fibroblast system allowed for easier detection and analysis of mitotic figures. Thus, in (Table 2 ). In particular, anaphase bridges, lagging chromosomes and micronuclei were detected at a higher frequency B-cell lymphomagenesis in transgenic mice E Chen et al (Figure 7b ). This indicates that the source of aneuploidy subsequent to Ubr1 loss in HOX11-overexpressing cells likely arises as a result of defects in chromosome segregation during spindle retraction during anaphase and is likely not due to errors during congression to the metaphase plane.
Discussion
In this study, we report the Ubr1 gene locus as a frequent integration site during the evolution of B-cell lymphomagenesis in IgHm-HOX11 Tg mice following mAIDS inoculation, comcomitant with downregulated expression of the Ubr1 gene product at the mRNA and protein level. In addition, single cell RT-PCR analysis detected a distinct subpopulation of cells devoid of Ubr1 expression, suggesting that a clonal advantage was gained by the loss of both Ubr1 loci. However, given the polyclonal nature of the lymphoma phenotype induced by the mAIDS virus (Klinken et al., 1988) , the loss of Ubr1 was likely not the sole oncogenic event leading to tumor formation and it is likely that additional genetic lesions are introduced by the virus. Nevertheless, that a significant proportion of cells with loss of the Ubr1 gene is indeed detected in HOX11-expressing lymphomatous tissues suggests a potentially novel tumor suppressor function for Ubr1. B-cell lymphomagenesis in transgenic mice E Chen et al Kwon et al. (1998 Kwon et al. ( , 2001 Kwon et al. ( , 2003 previously characterized two functionally overlapping ubiquitin ligases (UBR1 and UBR2) of the N-end rule pathway. UBR1 and UBR2 with sizes of 200 kDa share 44% overall identity with each other, and recognize type 1 (Arg, Lys and His) and type 2 (Phe, Leu, Trp, Tyr and Ile) Nterminal destabilizing residues for ubiquitin-dependent proteolysis. It remains to be tested whether Ubr2 inactivation is also associated with HOX11-induced lymphomagenesis. However, that we have thus far identified only insertions into the Ubr1 gene suggests that Ubr1 and Ubr2 may have distinct physiological functions especially with respect to lymphomagenesis. Consistent with this speculation, Ubr1 À/À mice were viable and displayed only subtle defects in muscle protein degradation and fat metabolism (Kwon et al., 2001) , whereas Ubr2 À/À male mice were infertile owing to defects in homologous chromosome pairing during meiotic prophase 1, and Ubr2 À/À female embryos were non-viable without specific terminal phenotypes (Kwon et al., 2003) . Mammalian proteins whose in vivo degradation depends on the ubiquitin ligase activity of Ubr1 remain unknown. It has been reported that in S. cerevisiae UBR1 is essential for chromosome stability, through degradation, at the metaphase-anaphase transition, of a fragment of SCC1, a component of the cohesin complexes that is involved in sister chromatid adhesion (Rao et al., 2001) . Relevant with this finding, human UBR1 and UBR2 have been shown to form a stable complex, mainly in the cytoplasm, with RECQL4, a member of the RecQ helicase family whose mutations were found in the Rothmund-Thomson and Rapadilino syndromes (Yin et al., 2004) . These syndromes have clinical features that include a predisposition to cancer.
These results collectively implicate Ubr1 in maintenance of chromosome stability. Based on these findings, we investigated whether a similar phenotype could be seen in IgHm-HOX11 Tg /Ubr1 À/À mice. Although there was a modest acceleration of lymphoma onset in IgHm-HOX11
Tg

/Ubr1
À/À mice, a more pronounced effect was observed in the B lymphocytes isolated from these animals. Although significant chromosomal abnormalities in primary B lymphocyte cultures derived from IgHm-HOX11 Tg or Ubr1 À/À mice were not detected, the combination of overexpression of HOX11 in conjunction with loss of Ubr1 proved to be sufficient in disrupting mitotic chromosome segregation.
That Ubr1 À/À mice were phenotypically normal except for only subtle physiological defects (Kwon et al., 2001) suggests that, by itself, loss of Ubr1 is not oncogenic. However, the oncogenic effect of Ubr1 gene ablation may exhibit a greater effect in a HOX11 background than in a WT background. The mechanism of synergy between HOX11 overexpression and Ubr1 loss may involve HOX11's role in regulating cell cycle progression. HOX11 overexpression has previously been implicated in aberrant regulation of both G1/S progression (Riz and Hawley, 2005) and transition into mitosis (Kawabe et al., 1997) . Recently, we reported that ectopic expression of HOX11 facilitates the ability to aberrantly bypass mitotic arrest induced by aneugenic stress (Chen et al., 2006) . We speculate that HOX11 overexpression could be promoting the accumulation of aneuploid cells by allowing chromosome segregation errors contributed by the loss of Ubr1 to go 'unchecked' at appropriate cell cycle checkpoints.
Such a proposed mechanism would predict that HOX11-positive tumors would be particularly prone to B-cell lymphomagenesis in transgenic mice E Chen et al chromosome instability. Indeed, we have previously reported other HOX11 collaborating genes (in addition to Ubr1) identified through our proviral insertional mutagenesis screen in IgHm-HOX11 Tg mice which are known to function in the regulation of chromosome segregation and whose expression is disrupted in HOX11-positive lymphomas (Chen et al., 2006) . The overwhelming preponderance of targets involving genes that play a role in the regulation of chromosome segregation strongly suggests that HOX11-associated tumors are particularly susceptible to mutations in genes involved in the regulation of chromosome stability. Moreover, we have reported that the tumors arising in IgHm-HOX11 Tg mice exhibit a high degree of chromosome instability and are highly aneuploid when grown ex vivo. Paradoxically, in all four tumors examined, there was an increased tendency towards hyperdiploidy rather than hypodiploidy. However, the hyperdiploidy seen in tumors developing in IgHm-HOX11
Tg mice is consistent with the karyotypes of the HOX11-positive cell lines, K3P and SIL, which are both hypertetraploid, containing in excess of 90 chromosomes. It is possible that the hypodiploidy observed in the IgHm-HOX11
Tg /Ubr1 À/À B-cell cultures represents an early stage of tumorigenesis, whereby loss of Ubr1 leads to defects in fidelity of chromosome segregation during mitosis, facilitating the loss of heterozygosity or haploinsufficiency of key tumor suppressor molecules, with subsequent mutations being required for the dramatic chromosome instability stage associated with the later stages of tumor progression. Such a mechanistic explanation whereby aneuploidy induced by the loss of the Ubr1 gene in facilitating the early steps of tumorigenesis is potentially rate limited by the likelihood of cell death in the presence of excessive loss of genetic material. This inefficient tumorigenic process may account for the low incidence and long latency of cancer development in the IgHm-HOX11 Tg /Ubr1 À/À mice. Future studies to generate compound transgenic mice overexpressing HOX11 in conjunction with other, more central regulators of chromosome segregation may be able to shed light on this paradox and reaffirm the applicability of this disease paradigm in HOX11-associated lymphomagenesis.
Materials and methods
Reverse transcriptase-PCR analysis
Reverse transcriptase-PCR analysis was performed using the SuperScript II First-Strand cDNA Synthesis Kit (Invitrogen, Burlington, ON, USA) according to manufacturer's protocols. PCR analysis was performed using 2 ml of the reverse transcription reaction product and the following primers: UBR1F53: 5 0 -CCACAGGTTTCCGCTAGCTG-3 0 ; UBR1R 3295: 5 0 -CTTCTGACGTATTATCATACATGA-3 0 ; UBR1F3 095: 5 0 -CATGATAACATGGATACTCCAGA-3 0 ; UBR1R57 23: 5 0 -CACTCATGATTGTCTTGAGGCAGA-3 0 . Thermocycling conditions were an initial denaturation step at 941C for 3 min, followed by 30 cycles of 941C for 30 s, 551C for 30 s and 721C for 1 min.
Immunoblotting analysis
Proteins were separated on SDS-polyacrylamide gel electrophoresis, blotted to nitrocellulose membrane, and probed at various dilutions with a primary antibody recognizing HOX11 (1:2000), UBR1 (1:1000), UBC2 (1:500), PBX1 (1:200), b-actin (1:2000), cyclin B1 (1:200) or gp94 (1:1000) for 4 h at room temperature, followed by three washes with PBST for 20 min each. Membranes were subsequently incubated with either anti-mouse (1:10 000) or anti-rabbit (1:10 000) antibody conjugated to horseradish peroxidase for 1 h at room temperature. The anti-UBR1 antibody was previously described (Kwon et al., 2001) . All other antibodies were obtained from Santa Cruz Biotechnologies (Santa Cruz, CA, USA). Densitometric analysis was performed using the Bandleader software.
Single-cell reverse transcriptase-PCR analysis B lymphocytes were isolated from tumor tissues using the MACS magnetic bead sorting system and a magnetically labeled antibody specific for the pan B-cell antigen B220 (Miltenyi Biotech, Auburn, CA, USA). All procedures were performed according to manufacturer's instructions. Positively sorted cells were stained with a phycoerythrin-conjugated B220 antibody and sorted into single wells of a round-bottom 96-well plate by FACS. Each well was visually examined to ensure it contained only one cell. Multiplex single-cell RT-PCR was performed on single cells to assess levels of B220 mRNA and Ubr1 mRNA using the one-step RT-PCR kit (Qiagen, Mississauga, ON, USA) according to manufacturer's instructions. Each cell was resuspended directly in the complete reaction cocktail and directly subjected to reverse transcription for 30 min at 501C, followed immediately by thermocycling. Conditions for the first PCR step involved an initial denaturation step at 941C for 15 min, followed by 30 cycles of 941C for 30 s, 501C for 30 s and 721C for 1 min. For each PCR reaction, 0.6 mM of the forward and reverse Ubr1 and B220 primers and the reverse Du5H mAIDS primer were used. Polymerase chain reaction products were then diluted 100-fold in nuclease-free water, and subjected to separate nested PCR reactions, using thermocycling conditions of 30 cycles of 941C for 30 s, 601C for 30 s and 721C for 1 min for B220 amplification. For multiplex amplification of Ubr1 and Ubr1-mAIDS transcripts, the annealing temperature was lowered to 531C. The primers used were: UBR1-F: 5 0 -ATCGTTACAAG ATGCATACTTC-3 0 ; UBR1-R: 5 0 -CTTGGTACTGGACAT GAAATTTGT-3 0 ; UBR1-Fn: 5 0 -CCACGAGAGAAGCATC TCCATA-3 0 ; UBR1-Rn: 5 0 -AAGCCACCAGTAAGAGATC TTC-3 0 ; B220-F: 5 0 -AATGGAGTGTACGAGGGAGATT-3 0 ; B220-R: 5 0 -TGGCATTTATGTAGGTGGACCC-3 0 ; B220-Fn: 5 0 -GCTATGATCTGCGCAAGAAAAG-3 0 ; B220-Rn: 5 0 -CTTTCGGGCATCTTTGATGGGA-3 0 ; Du5H-R: 5 0 -CCA CAGATATCCTGTTTGGCCT-3 0 ; Du5H-Rn: 5 0 -TCCAT GCCTTGCAAGATGGCGT-3 0 . The sensitivity of the RT-PCR reaction was determined as being capable of detecting Ubr1 or B220 transcripts from 10 fg total RNA.
Construction of C57BL6/J Ubr1
À/À mice and IgHm-HOX11 Tg / Ubr1 À/À mice Construction of Ubr1 À/À mice on the C57BL6/129 mixed genetic background has been previously described (Kwon et al., 2001) . F2 C57BL6/129SvJ Ubr1 þ /À males were backcrossed with WT C57BL6/J females, yielding BF10 generation. IgHm-HOX11 Tg /Ubr1 À/À mice were generated by crossing IgHm-HOX11 Tg mice with Ubr1 À/À mice. Genotyping for the Ubr1 allele and the HOX11 transgene was described previously (Hough et al., 1998; Kwon et al., 2001 ).
Preparation of splenic B lymphocytes and generation of primary B lymphocyte cultures Splenocytes were isolated from 1 to 2-month-old mice by disruption of whole spleen tissues through a 40 mm nylon cell strainer. Cells were treated with 0.165 M NH 4 Cl-Tris for 15 min to lyse erythrocytes. Primary B lymphocytes were isolated using the MACS magnetic bead sorting system as described above (Miltenyi Biotech, Auburn, CA, USA). All procedures were performed according to the manufacturer's instructions. Flow cytometric analysis of purified cells indicated a purity of B cells of >90%. Purified B220 þ B lymphocytes were maintained at a cell density of 2 Â 10 6 cells per ml in Dulbecco's modified Eagle's medium (DMEM) supplemented with 20% fetal calf serum (FCS), 2 mM L-glutamine, 1% penicillin/streptomycin, 0.05% anti-CD40 antibody (Pharmingen) and 10 ng/ml recombinant murine interleukin-4 Media change was performed 48 h after initiation of cultures.
Ubr1 short interfering RNA knockdown in K3P, SIL and HOX11-3T3 fibroblast cell lines K3P and SIL T cell lines were maintained in RPMI medium supplemented with 10% FCS, 2 mM L-glutamine and 1% penicillin/streptomycin. HOX11-3T3 fibroblasts were maintained inDMEM supplemented with 10% FCS, 2 mM Lglutamine and 1% penicillin/streptomycin. Short interfering RNAs targeting Ubr1 (5 0 -AAGGAUCCGGAUAUUUGC UUA-3 0 ), the scrambled RNA control (5 0 -AAGAGCUGCAG AUGUUCUUAU-3 0 ) or the rhodamine-labeled RNA oligonucleotide control were designed and provided by Ambion (Austin, TX, USA). For siRNA transient transfection, 3 mg of RNA was transfected into 40-60% confluent HOX11-3T3 cultures or K3P or SIL cells at a cell density of 5 Â 10 5 cells/ml using the TransMessenger Transfection Reagent (Qiagen), according to the manufacturer's protocols.
Micronucleus assay HOX11-3T3 cultures at 40 to 60% confluency, K3P or SIL cells at a cell density of 1 Â 10 6 cells/ml or day 4 primary B lymphocytes cultures were treated with 3 mg/ml cytochalasin B (Sigma, St Louis, MO) overnight. Cells were collected by centrifugation at 1000 r.p.m. for 10 min, fixed and washed once in 25:1 methanol:glacial acetic acid solution (MG fixative), and resuspended in MG fixative at B100 000 cells per ml. Approximately 10 drops of the cell suspension were dropped onto a horizontally held slide, and the slides were air dried for 1 h at room temperature. Slides were stained with 10 mg/ml acridine orange (Sigma) for 2 min, followed by two washes with dH 2 O. Stained slides were scored under fluorescent microscopy. For each independent culture, 1000 binuceated cells were scored.
